4.7 Article

Mutant Prevention Concentrations of Four Carbapenems against Gram-Negative Rods

期刊

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 54, 期 6, 页码 2692-2695

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00033-10

关键词

-

资金

  1. AstraZeneca Pharmaceuticals, Wilmington, DE

向作者/读者索取更多资源

We tested the propensities of four carbapenems to select for resistant Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii mutants by determining the mutant prevention concentrations (MPCs) for 100 clinical strains with various beta-lactam phenotypes. Among the members of the Enterobacteriaceae family and A. baumannii strains, the MPC/MIC ratios were mostly 2 to 4. In contrast, for P. aeruginosa the MPC/MIC ratios were 4 to >= 16. The MPC/MIC ratios for beta-lactamase-positive K. pneumoniae and E. coli isolates were much higher (range, 4 to > 16 mu g/ml) than those for beta-lactamase-negative strains.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据